21 CFR 1107.46
§ 1107.46 Issuance of an order finding a new tobacco product substantially equivalent.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 1107.46, § 1107.46 Issuance of an order finding a new tobacco product substantially equivalent, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91523
- Permanent ID
ys:prov:91523@1- SHA-256
c4b84a94d2e64d93d4962a47d900651e7f1dd231f2e21546f14ff7f9c9896fd1
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
If FDA finds that the information submitted in the SE Report establishes that the new tobacco product is substantially equivalent to a predicate tobacco product that was commercially marketed (other than for test marketing) in the United States on February 15, 2007, and finds that the new tobacco product is in compliance with the requirements of the Federal Food, Drug, and Cosmetic Act, FDA will send the applicant an order authorizing marketing of the new tobacco product. A marketing authorization order becomes effective on the date the order is issued.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.